Publications by authors named "Christopher L Neal"

Claim this Profile
1
14-3-3ζ as a prognostic marker and therapeutic target for cancer.
Christopher L Neal, Dihua Yu

Expert Opin Ther Targets· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation.
Shau-Hsuan Li, Valerie S Hawthorne, Christopher L Neal, Sartaj Sanghera, Jia Xu

Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival.
Christopher L Neal, Jun Yao, Wentao Yang, Xiaoyan Zhou, Nina T Nguyen

Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.
Valerie S Hawthorne, Wen-Chien Huang, Christopher L Neal, Ling-Min Tseng, Mien-Chie Hung

Mol Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling.
Christopher G Danes, Shannon L Wyszomierski, Jing Lu, Christopher L Neal, Wentao Yang

Cancer Res· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.
Chien-Hsing Lu, Shannon L Wyszomierski, Ling-Ming Tseng, Meng-Hong Sun, Keng-Hsueh Lan, Christopher L Neal

Clin Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide.
Ming Tan, Keng-Hsueh Lan, Jun Yao, Chien-Hsing Lu, Menghong Sun, Christopher L Neal

Cancer Res· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis.
Ming Tan, Tong Jing, Keng-Hsueh Lan, Christopher L Neal, Ping Li

Mol Cell· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis